Michael Byrnes
2021 - eFFECTOR Therapeutics
In 2021, Michael Byrnes earned a total compensation of $1.2M as Chief Financial Officer at eFFECTOR Therapeutics, a 100% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $134,400 |
|---|---|
| Salary | $390,865 |
| Stock Awards | $687,217 |
| Other | $29,172 |
| Total | $1,241,654 |
Byrnes received $687.2K in stock awards, accounting for 55% of the total pay in 2021.
Byrnes also received $134.4K in non-equity incentive plan, $390.9K in salary and $29.2K in other compensation.
Rankings
In 2021, Michael Byrnes' compensation ranked 7,993rd out of 12,406 executives tracked by ExecPay. In other words, Byrnes earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,993 out of 12,406 | 36th |
Division Manufacturing | 3,531 out of 5,492 | 36th |
Major group Chemicals And Allied Products | 1,569 out of 2,368 | 34th |
Industry group Drugs | 1,394 out of 2,089 | 33rd |
Industry Pharmaceutical Preparations | 1,033 out of 1,536 | 33rd |
Source: SEC filing on April 20, 2022.
Byrnes' colleagues
We found three more compensation records of executives who worked with Michael Byrnes at eFFECTOR Therapeutics in 2021.